AUTENTICA launches in the UK

Italian aesthetics manufacturer Regenyal Laboratories has introduced AUTENTICA to the UK, bringing a hyaluronic acid treatment designed to improve hydration, firmness and skin quality without adding visible volume to the professional market. The treatment is available through exclusive UK distributor Fox Pharma and pharmacy partner MedFx, with practitioner training courses beginning in October.

Described as a skin restructurer, AUTENTICA combines 64mg of ultra-pure hyaluronic acid per syringe with a dedicated injection approach called the Anti-Gravity Technique. Placement within the superficial adipose layer is central to the treatment’s intended effect, pairing improvements in skin quality with subtle structural support.

“For me, AUTENTICA represents an exciting and innovative movement within aesthetics because it sits somewhere between improving skin quality and creating a subtle structural effect. It isn't simply about adding hydration, but rather enhancing the skin in a precise way through the Anti-Gravity Technique™. This allows for a much more considered approach to product placement, with the aim of supporting the skin's natural structure and creating a subtle lifting effect,” says Dr Hasaneen Al Janabi, founder of Dr Hass Clinic and lead UK key opinion leader for AUTENTICA.

The formulation uses Regenyal’s proprietary PHYSIOLOGIC TECH, combining high molecular weight hyaluronic acid with a controlled production process to create a stable structure without chemical cross-linkers or BDDE. Its introduction builds on the Italian manufacturer’s work with hyaluronic acid technologies since its establishment in 2007.

Training forms a central part of the UK rollout, reflecting the treatment’s specific placement technique and protocol.

“Regenyal has spent close to two decades refining the hyaluronic acid technology behind this launch. Bringing it to the UK means clinics will receive the product and the training together, which is the best possible way to introduce an innovative technique-led treatment like this,” says John Thompson, Managing Director of Fox Pharma.

Alongside courses from October, an introductory event for clinics and prospective training partners will take place at King Street Townhouse on 10 November 2026. AUTENTICA is available now through Fox Pharma and MedFx.